Wireless Telecom (WTT) 10-Q 14 Nov 13 2013 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 08, 2013
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'WIRELESS TELECOM GROUP INC	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	24,033,231
Amendment Flag	'false	'
Entity Central Index Key	'0000878828	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Well-known Seasoned Issuer	'Yes	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2013	Dec. 31, 2012
CURRENT ASSETS:	'	'
Cash and cash equivalents	$14,169,905	$12,969,513
Accounts receivable - net of allowance for doubtful accounts of $60,527 and $57,333 for 2013 and 2012, respectively	5,992,224	5,676,015
Inventories	8,817,034	8,289,635
Deferred income taxes - current	1,306,795	1,127,553
Prepaid expenses and other current assets	468,868	588,726
Asset held for sale	'	3,179,002
TOTAL CURRENT ASSETS	30,754,826	31,830,444
PROPERTY, PLANT AND EQUIPMENT - NET	1,554,588	1,266,692
OTHER ASSETS:	'	'
Goodwill	1,351,392	1,351,392
Deferred income taxes - non-current	6,820,785	6,084,042
Other assets	695,295	697,054
TOTAL OTHER ASSETS	8,867,472	8,132,488
TOTAL ASSETS	41,176,886	41,229,624
CURRENT LIABILITIES:	'	'
Accounts payable	911,081	1,258,426
Accrued expenses and other current liabilities	1,397,145	1,426,788
Equipment lease payable - current	120,103	'
Mortgage payable	'	2,629,215
TOTAL CURRENT LIABILITIES	2,428,329	5,314,429
LONG TERM LIABILITIES:	'	'
Equipment lease payable	89,322	'
COMMITMENTS AND CONTINGENCIES	'	'
SHAREHOLDERS’ EQUITY:	'	'
Preferred stock, $.01 par value, 2,000,000 shares authorized, none issued	'	'
Common stock, $.01 par value, 75,000,000 shares authorized, 29,232,557 and 29,012,557 shares issued, 24,033,231 and 23,987,972 shares outstanding, respectively	292,326	290,126
Additional paid-in-capital	38,703,935	38,226,921
Retained earnings	9,351,996	6,857,820
Treasury stock at cost, 5,199,326 and 5,024,585 shares, respectively	-9,689,022	-9,459,672
TOTAL SHAREHOLDERS’ EQUITY	38,659,235	35,915,195
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$41,176,886	$41,229,624

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Allowance for doubtful accounts (in Dollars)	$60,527	$57,333
Preferred stock, par value (in Dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	'	'
Common stock, par value (in Dollars per share)	$0.01	$0.01
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	29,232,557	29,012,557
Common stock, shares outstanding	24,033,231	23,987,972
Treasury stock, shares	5,199,326	5,024,585

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
NET SALES	$8,790,954	$7,385,241	$24,292,829	$21,379,106
COST OF SALES	4,555,655	3,685,575	12,656,839	10,734,537
GROSS PROFIT	4,235,299	3,699,666	11,635,990	10,644,569
OPERATING EXPENSES	'	'	'	'
Research and development	719,552	671,503	1,958,856	1,890,772
Sales and marketing	1,182,446	1,115,850	3,523,770	3,348,264
General and administrative	1,761,527	1,139,444	4,619,934	3,472,239
TOTAL OPERATING EXPENSES	3,663,525	2,926,797	10,102,560	8,711,275
OPERATING INCOME	571,774	772,869	1,533,430	1,933,294
OTHER (INCOME) EXPENSE	'	'	'	'
Interest expense - net	16,093	50,164	114,425	151,611
Other (income) - net	-176,629	-3,007	-490,218	-135,049
TOTAL OTHER (INCOME) EXPENSE	-160,536	47,157	-375,793	16,562
NET INCOME BEFORE INCOME TAXES	732,310	725,712	1,909,223	1,916,732
(BENEFIT) FROM INCOME TAXES	-357,681	-129,094	-584,953	-249,387
NET INCOME	$1,089,991	$854,806	$2,494,176	$2,166,119
INCOME PER COMMON SHARE:	'	'	'	'
BASIC (in Dollars per share)	$0.05	$0.04	$0.10	$0.09
DILUTED (in Dollars per share)	$0.04	$0.03	$0.10	$0.09

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES	'	'
Net income	$2,494,176	$2,166,119
Adjustments to reconcile net income to net cash provided by (used for) operating activities:	'	'
Depreciation and amortization	247,762	257,993
Stock compensation expense	479,214	218,464
Realized gain on sale of non-marketable security	-161,500	'
Realized gain on sale of building	-188,403	'
Deferred income taxes	-915,985	-536,836
Allowance for doubtful accounts	3,194	-64,383
Changes in assets and liabilities:	'	'
Accounts receivable	-319,403	-225,246
Inventories	-527,399	-832,713
Prepaid expenses and other assets	120,617	-178,319
Accounts payable, accrued expenses and other current liabilities	-346,206	499,841
Net cash provided by operating activities	886,067	1,304,920
CASH FLOWS FROM INVESTING ACTIVITIES	'	'
Capital expenditures	-352,747	-293,781
Proceeds from sale of non-marketable security	162,500	'
Proceeds from sale of building	3,393,919	'
Net cash provided by (used for) investing activities	3,203,672	-293,781
CASH FLOWS FROM FINANCING ACTIVITIES	'	'
Payments of mortgage note	-2,629,215	-54,749
Repayments of equipment lease payable	-30,782	'
Repurchase of treasury stock - 174,741 and 480,661 shares, respectively	-229,350	-583,016
Net cash (used for) financing activities	-2,889,347	-637,765
NET INCREASE IN CASH AND CASH EQUIVALENTS	1,200,392	373,374
Cash and cash equivalents, at beginning of period	12,969,513	12,089,782
CASH AND CASH EQUIVALENTS, AT END OF PERIOD	14,169,905	12,463,156
SUPPLEMENTAL INFORMATION:	'	'
Taxes	257,194	123,146
Interest	115,103	151,902
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'
Capital expenditures	-240,206	'
Equipment lease payable	$240,206	'

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Treasury stock repurchase, shares	174,741	480,661

CONDENSED_CONSOLIDATED_STATEME3

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Total
Balances at Dec. 31, 2012	$290,126	$38,226,921	$6,857,820	($9,459,672)	$35,915,195
Net income	'	'	2,494,176	'	2,494,176
Stock issued under equity compensation plan	2,200	-2,200	'	'	'
Stock compensation expense	'	479,214	'	'	479,214
Repurchase of treasury stock	'	'	'	-229,350	-229,350
Balances at Sep. 30, 2013	$292,326	$38,703,935	$9,351,996	($9,689,022)	$38,659,235

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES AND POLICIES	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES AND POLICIES
	The condensed consolidated balance sheets as of September 30, 2013, the condensed consolidated statements of operations for the three and nine-month periods ended September 30, 2013 and 2012, the condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2013 and 2012, and the condensed consolidated statement of shareholders’ equity for the nine-month period ended September 30, 2013 have been prepared by the Company without audit. The condensed consolidated financial statements include the accounts of Wireless Telecom Group, Inc., which operates one of its product lines under the trade name Noisecom, Inc. (“Noisecom”), and its wholly-owned subsidiaries Boonton Electronics Corporation (“Boonton”), Microlab/FXR (“Microlab”), WTG Foreign Sales Corporation and NC Mahwah, Inc., collectively the “Company”. All intercompany transactions and balances have been eliminated in consolidation.
	In the opinion of management, the accompanying condensed consolidated financial statements referred to above contain all necessary adjustments, consisting of normal accruals and recurring entries, which are necessary to present fairly the Company’s results for the interim periods being presented.
	The accounting policies followed by the Company are set forth in Note 1 to the Company’s financial statements included in its annual report on Form 10-K for the year ended December 31, 2012. Specific reference is made to that report since certain information and footnote disclosures normally included in financial statements in accordance with accounting principles generally accepted in the United States of America (US GAAP) have been condensed or omitted from this report.
	The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities (including inventory valuation, accounts receivable valuation, valuation of deferred tax assets and estimated fair values of stock options) and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of net sales and expenses during the reporting period. Actual results could differ from those estimates.
	The results of operations for the three and nine-month periods ended September 30, 2013 and 2012 are not necessarily indicative of the results to be expected for the full year.
	Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable.
	The Company maintains significant cash investments primarily with two financial institutions, which at times may exceed federally insured limits. The Company performs periodic evaluations of the relative credit rating of these institutions as part of its investment strategy.
	Concentrations of credit risk with respect to accounts receivable are limited due to the Company’s large customer base. At September 30, 2013 and December 31, 2012, primarily all of the Company’s receivables pertain to the telecommunications industry.
	The carrying amounts of cash and cash equivalents, trade receivables, other current assets and accounts payable approximate fair value due to the short-term nature of these instruments.
	The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of bank and money market accounts.
	Management has evaluated subsequent events for disclosure and/or recognition in the condensed consolidated financial statements through the date the financial statements were available to be issued.

RECENT_ACCOUNTING_PRONOUNCEMEN

RECENT ACCOUNTING PRONOUNCEMENTS	9 Months Ended
	Sep. 30, 2013
Accounting Changes and Error Corrections [Abstract]	'
Accounting Changes and Error Corrections [Text Block]	'
	NOTE 2 – RECENT ACCOUNTING PRONOUNCEMENTS
	In February 2013, the FASB issued ASU No. 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.” Under ASU 2013-02, an entity is required to provide information about the amounts reclassified out of Accumulated Other Comprehensive Income (“AOCI”) by component. In addition, an entity is required to present, either on the face of the financial statements or in the notes, significant amounts reclassified out of AOCI by the respective line items of net income, but only if the amount reclassified is required to be reclassified in its entirety in the same reporting period. For amounts that are not required to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures that provide additional details about those amounts. ASU 2013-02 does not change the current requirements for reporting net income or other comprehensive income in the financial statements. ASU 2013-02 was effective for the Company beginning January 1, 2013. The adoption of this ASU did not have a material impact on its condensed consolidated financial statements
	Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material impact on the accompanying condensed consolidated financial statements.

INCOME_TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	NOTE 3 – INCOME TAXES
	The Company records deferred taxes in accordance with ASC 740, “Accounting for Income Taxes”. This ASC requires recognition of deferred tax assets and liabilities for temporary differences between tax basis of assets and liabilities and the amounts at which they are carried in the financial statements, based upon the enacted rates in effect for the year in which the differences are expected to reverse. The Company establishes a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. The Company periodically assesses the value of its deferred tax asset and determines the necessity for a valuation allowance.
	Realization of the Company’s deferred tax assets is dependent upon the Company generating sufficient taxable income in future years to obtain benefit from the reversal of net deductible temporary differences and from utilization of net operating losses and tax credit carryforwards. The Company has recorded a valuation allowance due to the uncertainty related to the realization of certain deferred tax assets existing at September 30, 2013. A majority of the valuation allowance, or $7,012,134, relates to the Company’s foreign net operating loss carryforward which is unlikely to be realized in future periods. The balance of the valuation allowance, or $1,220,353, relates to the Company’s domestic net operating loss carryforward, which is evaluated for realization on a quarterly basis, as well as other timing differences. The amount of deferred tax assets considered realizable is subject to adjustment in future periods if estimates of future taxable income are changed. As a result of the Company’s evaluation of future estimated taxable income, management increased its net deferred tax asset by $484,907 and $915,985 for the three and nine-months ended September 30, 2013, respectively.
	The deferred income tax assets and (liabilities) are summarized as follows:
		September 30,			December 31,
		2013			2012
	Net deferred tax asset:
	Uniform capitalization of inventory costs for tax purposes	$	237,817		$	221,155
	Reserves on inventories – including demo inventory		526,368			499,001
	Allowance for doubtful accounts		24,211			22,933
	Accruals		210,000			195,149
	Tax effect of goodwill		(406,996	)		(321,636	)
	Book depreciation over tax		(221,689	)		(49,618	)
	Net operating loss carryforward		15,990,356			16,556,713
			16,360,067			17,123,697
	Valuation allowance for deferred tax assets		(8,232,487	)		(9,912,102	)
		$	8,127,580		$	7,211,595
	The Company analyzes its deferred tax asset on a quarterly basis and adjusts the deferred tax asset valuation allowance based on its rolling five-year projection of estimated taxable income, taking into consideration any limitations that may exist on its use of its net operating loss carryforwards.
	Under ASC 740, the Company must recognize the tax benefit from an uncertain position only if it is more-likely-than-not the tax position will be sustained on examination by the taxing authority, based on the technical merits of the position. The tax benefits recognized in the financial statements attributable to such position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon the ultimate resolution of the position.
	The components of income tax expense (benefit) related to income from operations are as follows:
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2013			2012			2013			2012
	Current:
	Federal	$	5,658		$	6,632		$	35,014		$	44,251
	State		121,568			81,111			296,018			243,198
	Deferred:
	Federal		(407,322	)		(192,985	)		(769,427	)		(477,784	)
	State		(77,585	)		(23,852	)		(146,558	)		(59,052	)
		$	(357,681	)	$	(129,094	)	$	(584,953	)	$	(249,387	)
	The Company has analyzed its filing positions in all of the Federal and state jurisdictions where it is required to file income tax returns. As of September 30, 2013 and December 31, 2012, the Company has identified its Federal tax return and its state tax return in New Jersey as “major” tax jurisdictions, as defined, in which it is required to file income tax returns. Based on the evaluations noted above, the Company has concluded that there are no significant uncertain tax positions requiring recognition or disclosure in its condensed consolidated financial statements.
	The State of New Jersey conducted a field examination of one of the Company’s subsidiary tax returns for the years 2009 through 2012 which was completed in October 2013. Based on the examination, the State of New Jersey did not propose any significant adjustments to the Company’s tax positions.

INCOME_PER_COMMON_SHARE

INCOME PER COMMON SHARE	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	NOTE 4 - INCOME PER COMMON SHARE
	Basic earnings per share is calculated by dividing income available to common shareholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share are calculated by using the weighted average number of shares of common stock outstanding and, when dilutive, potential shares from stock options and warrants to purchase common stock, using the treasury stock method.
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
	Weighted average common shares outstanding		23,979,970		24,233,260		23,902,547		24,322,647
	Potentially dilutive stock options		625,269		406,569		538,666		375,069
	Weighted average common shares outstanding, assuming dilution		24,605,239		24,639,829		24,441,213		24,697,716
	Common stock options are included in the diluted earnings per share calculation when the various option exercise prices are less than their relative average market price during the periods presented in this quarterly report. The weighted average number of options not included in diluted earnings per share, because the effects are anti-dilutive, was 2,466,731 and 1,855,430 for the three-months ended September 30, 2013 and 2012, respectively. For the nine-months ended September 30, 2013 and 2012, the weighted average number of options not included in diluted earnings per share was 2,554,580 and 1,923,938, respectively.

INVENTORIES

INVENTORIES	9 Months Ended
	Sep. 30, 2013
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	NOTE 5 – INVENTORIES
	Inventory carrying value is net of inventory reserves of $690,413 and $621,996 at September 30, 2013 and December 31, 2012, respectively.
	Inventories consist of:	September 30,		December 31,
		2013		2012
	Raw materials	$	5,228,805	$	5,186,555
	Work-in-process		902,282		390,188
	Finished goods		2,685,947		2,712,892
		$	8,817,034	$	8,289,635

GOODWILL

GOODWILL	9 Months Ended
	Sep. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets Disclosure [Text Block]	'
	NOTE 6 - GOODWILL
	Goodwill represents the excess of the aggregate purchase price over the fair value of the net assets acquired in a purchase business combination. Goodwill is not amortized but rather is reviewed for impairment at least annually, or more frequently if a triggering event occurs. Management first makes a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount before applying the two-step goodwill impairment test described below. If, based on the qualitative assessment, the estimated fair value is well in excess of its carrying amount, management will not perform any quantitative assessment. If, however, the conclusion is that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, management then performs a two-step goodwill impairment test. Under the first step, the fair value of the reporting unit is compared with its carrying value, and, if an indication of goodwill impairment exists for the reporting unit, the Company must perform step two of the impairment test (measurement). Under step two, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill as determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation.
	The residual fair value after this allocation is the implied fair value of the reporting unit’s goodwill. If the fair value of the reporting unit exceeds its carrying value, step two does not need to be performed.
	The Company’s goodwill balance of $1,351,392 at September 30, 2013 and December 31, 2012 relates to one of the Company’s reporting units, Microlab. Management’s qualitative assessment performed in the fourth quarter of 2012 did not indicate any impairment of Microlab’s goodwill as its fair value is estimated to be well in excess of its carrying value.

ACCOUNTING_FOR_STOCK_BASED_COM

ACCOUNTING FOR STOCK BASED COMPENSATION	9 Months Ended
	Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	NOTE 7 - ACCOUNTING FOR STOCK BASED COMPENSATION
	The Company follows the provisions of ASC 718, “Share-Based Payment.” The Company’s results for the three and nine-month periods ended September 30, 2013 include share-based compensation expense totaling $316,081 and $479,214, respectively. Results for the three and nine-month periods ended September 30, 2012 include share-based compensation expense of $90,899 and $218,464, respectively. Such amounts have been included in the Condensed Consolidated Statements of Operations within operating expenses.
	On June 13, 2012, our shareholders approved the Company’s 2012 Incentive Compensation Plan (the “2012 Plan”). The 2012 Plan replaced the Company’s Amended and Restated 2000 Stock Option Plan, as amended (the “Prior Plan”), under which 0 additional grants will be made. Under the 2012 Plan, the total number of shares of the Company’s common stock reserved and available for issuance under the 2012 Plan at any time is 2,000,000 shares, plus any shares subject to awards that have been issued under the Prior Plan that expire, are cancelled or are terminated after June 13, 2012 without having been exercised in full and would have become available for subsequent grants under the Prior Plan. As of September 30, 2013, there were 691,304 shares available for issuance under the 2012 Plan. The 2012 Plan provides for the grant of Restricted Stock Awards, Non-Qualified Stock Options and Incentive Stock Options in compliance with the Internal Revenue Code of 1986, as amended, to employees, officers, directors, consultants and advisors of the Company who are expected to contribute to the Company’s future growth and success.
	All service-based options granted have ten-year terms and, from the date of grant, vest annually and become fully exercisable after a maximum of five years. Performance-based options granted have ten-year terms and vest and become fully exercisable when determinable performance targets are achieved. Performance targets are agreed to, and approved by, the Company’s board of directors.
	Under the Company’s 2012 Plan, options may be granted to purchase shares of the Company’s common stock exercisable at prices equal to or above the fair market value on the date of the grant.
	The following table summarizes the restricted common stock awards granted to certain officers and directors of the Company during the nine-months ended September 30, 2012 under the 2012 Plan:
		Number of Shares			Price per
	Individuals	Granted			Granted Share		Vesting Date
	Chief Executive Officer		50,000		$	1.15	13-Jun-12		(vested upon grant)
			26,957		$	1.15	20-Mar-13
	V.P. of Sales and Marketing		21,739		$	1.15	20-Mar-13
	Board of Directors		80,000		$	1.15	13-Jun-12		(vested upon grant)
			80,000		$	1.15	13-Jun-13
			258,696
	On August 19, 2013, upon the unanimous recommendation of the Compensation Committee, the Board of Directors approved the grant of performance-based restricted stock awards to certain employees of the Company, including its officers. Accordingly, the Company entered into restricted stock agreements pursuant to which certain employees of the Company were awarded, collectively, up to 100,000 shares of the Company’s common stock at $1.77 per share, which represents the closing price of the Company’s common stock as reported on the NYSE MKT on August 19, 2013, the date of grant.
	Under the terms of the restricted stock agreements, the awards will fully vest and become exercisable on the date on which the Board shall have determined that specific financial milestones have been met, provided the employee remains in the employ of the Company at such time; provided, however, upon a Change in Control (as defined in the stock option agreements and the 2012 Plan), the restricted stock shall automatically vest as permitted by the 2012 Plan. For the performance-based restricted stock awarded in 2013, the Company’s Board of Directors adopted specific revenue and earnings performance targets as vesting conditions. As of September 30, 2013, the Company has not incurred expense relating to these performance-based stock awards as it is more likely than not that the performance targets will not be achieved.
	The following table summarizes the restricted common stock awards granted to certain directors, officers and employees of the Company during the nine-months ended September 30, 2013 under the 2012 Plan:
		Number of Shares			Price per
	Individuals	Granted			Granted Share		Vesting Date
	Chief Executive Officer		42,000		$	1.77	Performance based
	Chief Financial Officer		11,000		$	1.77	Performance based
	V.P. of Sales and Marketing		26,000		$	1.77	Performance based
	Various Other Employees		21,000		$	1.77	Performance based
	Board of Directors		120,000		$	1.51	Next Annual Meeting		(Expected June 2014)
			220,000
	During the nine-months ended September 30, 2013, the Company repurchased 13,479 shares of restricted common stock from its Chief Executive Officer and 10,870 shares of restricted common stock from its V.P. of Sales and Marketing for $36,279, or $1.49 per share, During the nine-months ended September 30, 2012, the Company repurchased 23,334 shares of restricted common stock from its Chief Executive Officer for $26,834, or $1.15 per share. In accordance with the terms of the 2012 Plan, the Compensation Committee of the Board of Directors authorized the Company to repurchase, upon vesting of the restricted stock, that certain number of shares necessary to allow such grantees to satisfy their personal tax liability associated with the vesting of such shares.
	A summary of the status of the Company’s non-vested restricted common stock, as granted under the Company’s approved stock compensation plan, as of September 30, 2013, and changes during the nine-months ended September 30, 2013 are presented below:
					Weighted Average
					Grant Date
	Non-vested Shares	Number of Shares			Fair Value
	Non-vested at January 1, 2013		128,696		$	1.15
	Granted		220,000		$	1.63
	Vested		(128,696	)	$	1.15
	Non-vested at September 30, 2013		220,000		$	1.63
	As of September 30, 2013, the unearned compensation related to Company granted restricted common stock is $312,900 of which $135,900 will be amortized on a straight-line basis through the date of the Company’s next annual shareholders meeting to be held in 2014, the vesting date. The remaining balance of $177,000 will begin to be amortized when certain performance conditions are determined to be probable.
	On August 19, 2013, upon the unanimous recommendation of the Compensation Committee, the Board of Directors approved the grant of performance-based stock options to certain employees of the Company, including its officers. Accordingly, the Company entered into stock option agreements pursuant to which certain employees of the Company were awarded options to purchase, collectively, up to 950,000 shares of the Company’s common stock at an exercise price of $1.77 per share, which represents the closing price of the Company’s common stock as reported on the NYSE MKT on August 19, 2013, the date of grant.
	Under the terms of the stock option agreements the options will fully vest and become exercisable on the date on which the Board shall have determined that specific financial milestones have been met, provided the employee remains in the employ of the Company at such time; provided, however, upon a Change in Control (as defined in the stock option agreements and the 2012 Plan), the options shall automatically accelerate and become fully exercisable as permitted by the 2012 Plan. For the performance-based stock options awarded in 2013, the Company’s Board of Directors adopted specific revenue and earnings performance targets as vesting conditions. As of September 30, 2013, the Company has not incurred expense relating to these performance-based stock options as it is more likely than not that the performance targets will not be achieved.
	A summary of performance-based stock option activity, and related information for the nine-months ended September 30, 2013 follows:
					Weighted Average
		Options			Exercise Price
	Outstanding, January 1, 2013		1,300,000		$	0.93
	Granted		950,000		$	1.77
	Exercised		—			—
	Forfeited		—			—
	Canceled/Expired		—			—
	Outstanding, September 30, 2013		2,250,000		$	1.28
	Options exercisable, September 30, 2013		—			—
	The aggregate intrinsic value of performance-based stock options outstanding as of September 30, 2013 and December 31, 2012 was $1,671,250 and $416,150, respectively. The aggregate intrinsic value of performance-based stock options exercisable as of September 30, 2013 was $0.
	The per share fair-value of performance-based options granted during the three and nine-month periods ended September 30, 2013 was $0.91.
	A summary of service-based stock option activity, and related information for the nine-months ended September 30, 2013 follows:
					Weighted Average
		Options			Exercise Price
	Outstanding, January 1, 2013		862,000		$	2.61
	Granted		—			—
	Exercised		—			—
	Forfeited		—			—
	Canceled/Expired		(20,000	)	$	1.95
	Outstanding, September 30, 2013		842,000		$	2.63
	Options exercisable, September 30, 2013		842,000		$	2.63
	The Company’s service-based stock options are fully amortized. The Company began amortizing its performance-based options at the end of 2011. For the three-months ended September 30, 2013 and 2012, the Company recorded compensation expense in the amount of $270,781 and $49,232, respectively. For the nine-months ended September 30, 2013 and 2012, the Company recorded compensation expense in the amount of $369,246 and $147,697, respectively. Through June 30, 2013, the unamortized amount was expensed on a straight-line basis through December 31, 2015, the expected implicit service period at that time. However, during the three-months ended September 30, 2013, management re-evaluated the date the respective performance conditions will likely be met. As a result, the Company has accelerated the expensing of such options through December 31, 2013, the revised implicit service date. The impact of the accelerated expense on net income for the three and nine-months ended September 30, 2013 was $221,548 or $0.01 per basic and diluted share. The unamortized balance of this tranche of options was $221,548 at September 30, 2013.
	Unearned compensation in the amount of $867,683 relating to performance-based stock options granted in 2013 will not be recognized until management considers the respective performance conditions to be achievable.
	The following summarizes the components of share-based compensation expense by equity type for the three and nine-months ended September 30:
		Three Months Ended					Nine Months Ended
September 30,					September 30,
	2013			2012		2013			2012
Performance-Based Stock Options	$	270,781		$	49,232	$	369,246		$	147,697
Restricted Common Stock		45,300			41,667		109,968			70,767
Total Share-Based Compensation Expense	$	316,081		$	90,899	$	479,214		$	218,464
Stock-based compensation for the three and nine-months ended 2013 and 2012 is included in general and administrative expenses in the accompanying condensed consolidated statement of operations.

SEGMENT_INFORMATION

SEGMENT INFORMATION	9 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	NOTE 8 – SEGMENT INFORMATION
	The Company, in accordance with ASC 280, “Disclosures about Segments of an Enterprise and Related Information”, has disclosed the following segment information:
	The operating businesses of the Company are segregated into two reportable segments, test and measurement and network solutions. The test and measurement segment is comprised primarily of the Company’s operations and the operations of its subsidiary, Boonton. The network solutions segment is comprised primarily of the operations of the Company’s subsidiary, Microlab.
	The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. The Company allocates resources and evaluates the performance of segments based on income or loss from operations, excluding interest, corporate expenses and other income (expenses).
	Financial information by reportable segment for the three and nine-months ended September 30, 2013 and 2012:
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2013			2012			2013			2012
	Net sales by segment:
	Test and measurement	$	2,519,184		$	4,297,887		$	8,273,080		$	11,745,402
	Network solutions		6,271,770			3,087,354			16,019,749			9,633,704
	Total consolidated net sales and net sales of reportable segments	$	8,790,954		$	7,385,241		$	24,292,829		$	21,379,106
	Segment income:
	Test and measurement	$	125,540		$	976,914		$	660,712		$	2,124,823
	Network solutions		1,782,916			597,871			4,094,938			2,157,285
	Income from reportable segments		1,908,456			1,574,785			4,755,650			4,282,108
	Other unallocated amounts:
	Corporate expenses		(1,336,682	)		(801,916	)		(3,222,220	)		(2,348,814	)
	Interest and other income - net		160,536			(47,157	)		375,793			(16,562	)
	Consolidated income before income tax (benefit)	$	732,310		$	725,712		$	1,909,223		$	1,916,732
	Depreciation and amortization by segment:
	Test and measurement	$	48,366		$	70,114		$	161,142		$	206,979
	Network solutions		31,196			18,378			86,620			51,014
	Total depreciation and amortization for reportable segments	$	79,562		$	88,492		$	247,762		$	257,993
	Capital expenditures by segment:
	Test and measurement	$	85,048		$	58,296		$	218,427		$	167,199
	Network solutions		82,105			17,077			134,320			126,582
	Total consolidated capital expenditures by reportable segment	$	167,153		$	75,373		$	352,747		$	293,781
	Financial information by reportable segment as of September 30, 2013 and December 31, 2012:
		2013			2012
	Total assets by segment:
	Test and measurement	$	8,621,496		$	12,104,700
	Network solutions		10,252,469			8,864,541
	Total assets for reportable segments		18,873,965			20,969,241
	Corporate assets, principally cash and cash equivalents and deferred and current taxes		22,302,921			20,260,383
	Total consolidated assets	$	41,176,886		$	41,229,624
	Net consolidated sales by region were as follows:
		For the Three Months						For the Nine Months
		Ended September 30,						Ended September 30,
	Sales by region	2013			2012			2013			2012
	Americas	$	6,645,495		$	5,589,376		$	19,149,306		$	16,011,211
	Europe, Middle East, Africa (EMEA)		986,834			1,360,022			2,990,043			3,495,931
	Asia Pacific (APAC)		1,158,625			435,843			2,153,480			1,871,964
	Total Sales	$	8,790,954		$	7,385,241		$	24,292,829		$	21,379,106
	Net sales are attributable to a geographic area based on the destination of the product shipment. The majority of shipments in the Americas are to customers located within the United States. For the three-months ended September 30, 2013 and 2012, sales in the United States amounted to $6,169,718 and $5,227,114, respectively. For the nine-months ended September 30, 2013 and 2012, sales in the United States amounted to $17,820,068 and $14,849,766, respectively. For the three and nine-months ended September 30, 2013 and 2012, shipments to the EMEA region were not significantly concentrated in one country. Shipments to the APAC region were largely concentrated in China. For the three-months ended September 30, 2013 and 2012, sales in China amounted to $869,298 and $211,429, respectively. For the nine-months ended September 30, 2013 and 2012, sales in China amounted to $1,319,804 and $1,057,909, respectively.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	NOTE 9 - COMMITMENTS AND CONTINGENCIES
	Warranties:
	The Company typically provides one-year warranties on all of its products covering both parts and labor. The Company, at its option, repairs or replaces products that are defective during the warranty period if the proper preventive maintenance procedures have been followed by its customers. Historically, warranty expense within the Company has been minimal.
	Leases:
	The Company has a building lease agreement with its current landlord to remain at its principal corporate headquarters in Hanover Township, Parsippany, New Jersey through September 30, 2014. The current minimum monthly base rent payment is approximately $29,000.
	Environmental Contingencies:
	Following an investigation by the New Jersey Department of Environmental Protection (NJDEP) in 1982, of the waste disposal practices at a certain site formerly leased by Boonton, the Company put a ground water management plan into effect as approved by the NJDEP. Costs associated with this site are charged directly to income as incurred. The owner of this site has previously notified the Company that if the NJDEP investigation proves to have interfered with a sale of the property, the owner may seek to hold the Company liable for any resulting damages. Since May 1983, the owner has been on notice of this problem and has failed to institute any legal proceedings with respect thereto. While this does not bar the owner from instituting a suit, it is the opinion of the Company’s legal counsel that it is unlikely that the owner would prevail on any claim.
	The Company is diligently pursuing efforts to satisfy the requirements of the original plan and receive a new determination from the NJDEP. Overall data from testing performed in March 2013 indicates the continuation of a decreasing concentration trend at the site. The overall decrease supports the absence of a continuing source impacting ground water. The Company believes that its current practice and plan of groundwater testing will continue until an official notification from the NJDEP is obtained and the Company is released from further obligations. While management anticipates that the expenditures in connection with this site will not be substantial in future years, the Company could be subject to significant future liabilities and may incur significant future expenditures if further contaminants from Boonton’s testing are identified and the NJDEP requires additional remediation activities.
	Management is unable to estimate future remediation costs, if any, at this time. The Company will continue to be liable under the plan, in all future years, until such time as the NJDEP releases it from all obligations applicable thereto.
	Line of Credit:
	The Company maintains a line of credit with its investment bank. The credit facility provides borrowing availability of up to 100% of the Company’s money market account balance and 99% of the Company’s short-term investment securities (U.S. Treasury bills) and, under the terms and conditions of the loan agreement, the facility is fully secured by our money fund account and short-term investment holdings held with the bank. Advances under the facility will bear interest at a variable rate equal to the London InterBank Offered Rate (“LIBOR”) in effect at time of borrowing. Additionally, under the terms and conditions of the loan agreement, there is 0 annual fee and any amount outstanding under the loan facility may be paid at any time in whole or in part without penalty. As of September 30, 2013, the Company had 0 borrowings outstanding under the facility and approximately $4,500,000 of borrowing availability. The Company has no current plans to borrow from this credit facility as it believes its present cash balances will adequately meet near-term working capital requirements.
	Risks and Uncertainties:
	Proprietary information and know-how are important to the Company’s commercial success. There can be no assurance that others will not either develop independently the same or similar information or obtain and use proprietary information of the Company. Certain key employees have signed confidentiality and non-compete agreements regarding the Company’s proprietary information.
	The Company believes that its products do not infringe the proprietary rights of third parties. There can be no assurance, however, that third parties will not assert infringement claims in the future.

SALE_OF_BUILDING

SALE OF BUILDING	9 Months Ended
	Sep. 30, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	NOTE 10 - SALE OF BUILDING
	On August 1, 2013, the Company closed on the sale of a property previously owned by the Company and located in Mahwah, New Jersey (the “Mahwah Building”) and repaid the existing mortgage loan payable on the building with the proceeds of the sale. As part of the terms of the sale, the Company was required to place $350,000 in escrow until certain conditions are met, as determined by the State of New Jersey. The terms of the mortgage loan relating to the Mahwah Building required monthly payments of $23,750 applied to both principal and interest at the annual rate of 7.45%. As a result of the sale and the repayment of the mortgage loan, the Company recognized a gain of $188,403 and is no longer obligated to make any loan payments.

INCOME_TAXES_Tables

INCOME TAXES (Tables)	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'The deferred income tax assets and (liabilities) are summarized as follows:
		September 30,			December 31,
		2013			2012
	Net deferred tax asset:
	Uniform capitalization of inventory costs for tax purposes	$	237,817		$	221,155
	Reserves on inventories – including demo inventory		526,368			499,001
	Allowance for doubtful accounts		24,211			22,933
	Accruals		210,000			195,149
	Tax effect of goodwill		(406,996	)		(321,636	)
	Book depreciation over tax		(221,689	)		(49,618	)
	Net operating loss carryforward		15,990,356			16,556,713
			16,360,067			17,123,697
	Valuation allowance for deferred tax assets		(8,232,487	)		(9,912,102	)
		$	8,127,580		$	7,211,595
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	'The components of income tax expense (benefit) related to income from operations are as follows:
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2013			2012			2013			2012
	Current:
	Federal	$	5,658		$	6,632		$	35,014		$	44,251
	State		121,568			81,111			296,018			243,198
	Deferred:
	Federal		(407,322	)		(192,985	)		(769,427	)		(477,784	)
	State		(77,585	)		(23,852	)		(146,558	)		(59,052	)
		$	(357,681	)	$	(129,094	)	$	(584,953	)	$	(249,387	)

INCOME_PER_COMMON_SHARE_Tables

INCOME PER COMMON SHARE (Tables)	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Schedule of Weighted Average Number of Shares [Table Text Block]	'
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
	Weighted average common shares outstanding		23,979,970		24,233,260		23,902,547		24,322,647
	Potentially dilutive stock options		625,269		406,569		538,666		375,069
	Weighted average common shares outstanding, assuming dilution		24,605,239		24,639,829		24,441,213		24,697,716

INVENTORIES_Tables

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2013
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'Inventories consist of:
	Inventories consist of:	September 30,		December 31,
		2013		2012
	Raw materials	$	5,228,805	$	5,186,555
	Work-in-process		902,282		390,188
	Finished goods		2,685,947		2,712,892
		$	8,817,034	$	8,289,635

ACCOUNTING_FOR_STOCK_BASED_COM1

ACCOUNTING FOR STOCK BASED COMPENSATION (Tables)	9 Months Ended
	Sep. 30, 2013
ACCOUNTING FOR STOCK BASED COMPENSATION (Tables) [Line Items]	'
Schedule of Restricted Stock Awards Granted [Table Text Block]	'The following table summarizes the restricted common stock awards granted to certain officers and directors of the Company during the nine-months ended September 30, 2012 under the 2012 Plan:
		Number of Shares			Price per
	Individuals	Granted			Granted Share		Vesting Date
	Chief Executive Officer		50,000		$	1.15	13-Jun-12		(vested upon grant)
			26,957		$	1.15	20-Mar-13
	V.P. of Sales and Marketing		21,739		$	1.15	20-Mar-13
	Board of Directors		80,000		$	1.15	13-Jun-12		(vested upon grant)
			80,000		$	1.15	13-Jun-13
			258,696
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	'A summary of the status of the Company’s non-vested restricted common stock, as granted under the Company’s approved stock compensation plan, as of September 30, 2013, and changes during the nine-months ended September 30, 2013 are presented below:
					Weighted Average
					Grant Date
	Non-vested Shares	Number of Shares			Fair Value
	Non-vested at January 1, 2013		128,696		$	1.15
	Granted		220,000		$	1.63
	Vested		(128,696	)	$	1.15
	Non-vested at September 30, 2013		220,000		$	1.63
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]	'The following summarizes the components of share-based compensation expense by equity type for the three and nine-months ended September 30:
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2013			2012		2013			2012
	Performance-Based Stock Options	$	270,781		$	49,232	$	369,246		$	147,697
	Restricted Common Stock		45,300			41,667		109,968			70,767
	Total Share-Based Compensation Expense	$	316,081		$	90,899	$	479,214		$	218,464
Performance Based Stock Options [Member]	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Tables) [Line Items]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'A summary of performance-based stock option activity, and related information for the nine-months ended September 30, 2013 follows:
					Weighted Average
		Options			Exercise Price
	Outstanding, January 1, 2013		1,300,000		$	0.93
	Granted		950,000		$	1.77
	Exercised		—			—
	Forfeited		—			—
	Canceled/Expired		—			—
	Outstanding, September 30, 2013		2,250,000		$	1.28
	Options exercisable, September 30, 2013		—			—
Service Based Stock Options [Member]	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Tables) [Line Items]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'A summary of service-based stock option activity, and related information for the nine-months ended September 30, 2013 follows:
					Weighted Average
		Options			Exercise Price
	Outstanding, January 1, 2013		862,000		$	2.61
	Granted		—			—
	Exercised		—			—
	Forfeited		—			—
	Canceled/Expired		(20,000	)	$	1.95
	Outstanding, September 30, 2013		842,000		$	2.63
	Options exercisable, September 30, 2013		842,000		$	2.63
Performance Based Restricted Common Stock Awards [Member]	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Tables) [Line Items]	'
Schedule of Restricted Stock Awards Granted [Table Text Block]	'The following table summarizes the restricted common stock awards granted to certain directors, officers and employees of the Company during the nine-months ended September 30, 2013 under the 2012 Plan:
		Number of Shares			Price per
	Individuals	Granted			Granted Share		Vesting Date
	Chief Executive Officer		42,000		$	1.77	Performance based
	Chief Financial Officer		11,000		$	1.77	Performance based
	V.P. of Sales and Marketing		26,000		$	1.77	Performance based
	Various Other Employees		21,000		$	1.77	Performance based
	Board of Directors		120,000		$	1.51	Next Annual Meeting		(Expected June 2014)
			220,000

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]	'
Schedule Of Segment Reporting Financial Information Excluding Total Assets By Segment [Table Text Block]	'Financial information by reportable segment for the three and nine-months ended September 30, 2013 and 2012:
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2013			2012			2013			2012
	Net sales by segment:
	Test and measurement	$	2,519,184		$	4,297,887		$	8,273,080		$	11,745,402
	Network solutions		6,271,770			3,087,354			16,019,749			9,633,704
	Total consolidated net sales and net sales of reportable segments	$	8,790,954		$	7,385,241		$	24,292,829		$	21,379,106
	Segment income:
	Test and measurement	$	125,540		$	976,914		$	660,712		$	2,124,823
	Network solutions		1,782,916			597,871			4,094,938			2,157,285
	Income from reportable segments		1,908,456			1,574,785			4,755,650			4,282,108
	Other unallocated amounts:
	Corporate expenses		(1,336,682	)		(801,916	)		(3,222,220	)		(2,348,814	)
	Interest and other income - net		160,536			(47,157	)		375,793			(16,562	)
	Consolidated income before income tax (benefit)	$	732,310		$	725,712		$	1,909,223		$	1,916,732
	Depreciation and amortization by segment:
	Test and measurement	$	48,366		$	70,114		$	161,142		$	206,979
	Network solutions		31,196			18,378			86,620			51,014
	Total depreciation and amortization for reportable segments	$	79,562		$	88,492		$	247,762		$	257,993
	Capital expenditures by segment:
	Test and measurement	$	85,048		$	58,296		$	218,427		$	167,199
	Network solutions		82,105			17,077			134,320			126,582
	Total consolidated capital expenditures by reportable segment	$	167,153		$	75,373		$	352,747		$	293,781
Schedule Of Segment Reporting Information Total Assets By Segment [Table Text Block]	'Financial information by reportable segment as of September 30, 2013 and December 31, 2012:
		2013			2012
	Total assets by segment:
	Test and measurement	$	8,621,496		$	12,104,700
	Network solutions		10,252,469			8,864,541
	Total assets for reportable segments		18,873,965			20,969,241
	Corporate assets, principally cash and cash equivalents and deferred and current taxes		22,302,921			20,260,383
	Total consolidated assets	$	41,176,886		$	41,229,624
Schedule Of Net Consolidated Sales By Region [Table Text Block]	'Net consolidated sales by region were as follows:
		For the Three Months						For the Nine Months
		Ended September 30,						Ended September 30,
	Sales by region	2013			2012			2013			2012
	Americas	$	6,645,495		$	5,589,376		$	19,149,306		$	16,011,211
	Europe, Middle East, Africa (EMEA)		986,834			1,360,022			2,990,043			3,495,931
	Asia Pacific (APAC)		1,158,625			435,843			2,153,480			1,871,964
	Total Sales	$	8,790,954		$	7,385,241		$	24,292,829		$	21,379,106

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES AND POLICIES (Details)	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Number of Financial Institutions In Which Company Maintains Cash Investments	2
Highly Liquid Investment Maximum Maturity Period	'3 months

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2013
INCOME TAXES (Details) [Line Items]	'	'
Increase Decrease in Deferred Tax Assets Net	$484,907	$915,985
Rolling Period Consider for Projection Estimated Income	'	'5 years
Percentage Of Largest Benefit To Tax Benefits Recognized	'	50.00%
Income Tax Examination Period Under Examination	'	'2009 through 2012
Foreign Tax Authority [Member]	'	'
INCOME TAXES (Details) [Line Items]	'	'
Operating Loss Carryforwards, Valuation Allowance	7,012,134	7,012,134
Domestic Tax Authority [Member]	'	'
INCOME TAXES (Details) [Line Items]	'	'
Operating Loss Carryforwards, Valuation Allowance	$1,220,353	$1,220,353

INCOME_TAXES_Details_Schedule_

INCOME TAXES (Details) - Schedule of deferred tax assets and liabilities (USD $)	Sep. 30, 2013	Dec. 31, 2012
Net deferred tax asset:	'	'
Uniform capitalization of inventory costs for tax purposes	$237,817	$221,155
Reserves on inventories b including demo inventory	526,368	499,001
Allowance for doubtful accounts	24,211	22,933
Accruals	210,000	195,149
Tax effect of goodwill	-406,996	-321,636
Book depreciation over tax	-221,689	-49,618
Net operating loss carryforward	15,990,356	16,556,713
	16,360,067	17,123,697
Valuation allowance for deferred tax assets	-8,232,487	-9,912,102
	$8,127,580	$7,211,595

INCOME_TAXES_Details_Income_ta

INCOME TAXES (Details) - Income tax expense (Benefit) related to income from operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Current:	'	'	'	'
Federal	$5,658	$6,632	$35,014	$44,251
State	121,568	81,111	296,018	243,198
Deferred:	'	'	'	'
Federal	-407,322	-192,985	-769,427	-477,784
State	-77,585	-23,852	-146,558	-59,052
	($357,681)	($129,094)	($584,953)	($249,387)

INCOME_PER_COMMON_SHARE_Detail

INCOME PER COMMON SHARE (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Earnings Per Share [Abstract]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,466,731	1,855,430	2,554,580	1,923,938

INCOME_PER_COMMON_SHARE_Detail1

INCOME PER COMMON SHARE (Details) - Schedule of weighted average number of shares	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Schedule of weighted average number of shares [Abstract]	'	'	'	'
Weighted average common shares outstanding	23,979,970	24,233,260	23,902,547	24,322,647
Potentially dilutive stock options	625,269	406,569	538,666	375,069
Weighted average common shares outstanding, assuming dilution	24,605,239	24,639,829	24,441,213	24,697,716

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Inventory Disclosure [Abstract]	'	'
Inventory Valuation Reserves	$690,413	$621,996

INVENTORIES_Details_Schedule_o

INVENTORIES (Details) - Schedule of inventory current (USD $)	Sep. 30, 2013	Dec. 31, 2012
Schedule of inventory current [Abstract]	'	'
Raw materials	$5,228,805	$5,186,555
Work-in-process	902,282	390,188
Finished goods	2,685,947	2,712,892
	$8,817,034	$8,289,635

GOODWILL_Details

GOODWILL (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
GOODWILL (Details) [Line Items]	'	'
Goodwill	$1,351,392	$1,351,392
Microlab [Member]	'	'
GOODWILL (Details) [Line Items]	'	'
Goodwill	$1,351,392	$1,351,392

ACCOUNTING_FOR_STOCK_BASED_COM2

ACCOUNTING FOR STOCK BASED COMPENSATION (Details) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Year-End Adjustment [Member]

Year-End Adjustment [Member]

Year-End Adjustment [Member]

Year-End Adjustment [Member]

Performance Shares [Member]

Performance Based Stock Options [Member]

Performance Based Stock Options [Member]

Performance Based Stock Options [Member]

Various Other Employees [Member]

Chief Executive Officer [Member]

Chief Executive Officer [Member]

V P Of Sales And Marketing [Member]

Performance Based Stock Options [Member]

Performance Based Stock Options [Member]

Performance Based Stock Options [Member]

Performance Based Stock Options [Member]

ACCOUNTING FOR STOCK BASED COMPENSATION (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation

$316,081

$90,899

$479,214

$218,464

$270,781

$49,232

$369,246

$147,697

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share Based Payment Award Additional Grants to be Made (in Shares)

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

Stock or Units Available for Distributions (in Shares)

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in Shares)

691,304

'

691,304

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

'

'

'10 years

'

'

'

'

'

'10 years

'

'

'

'

'

'

'

Share Based Compensation Arrangement by Share Based Payment Award Maximum Period Consider for Option Fully Exercisable

'

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

$1.77

'

'

'

Amount of Repurchased Common Stock (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

13,479

23,334

10,870

Payments for Repurchase of Common Stock

'

'

36,279

26,834

'

'

'

'

'

'

'

'

'

'

'

'

Share Price (in Dollars per share)

$1.49

$1.15

$1.49

$1.15

'

'

'

'

'

'

'

'

'

'

'

'

Adjustments to Additional Paid in Capital, Share-based Compensation, Restricted Stock Unit or Restricted Stock Award, Requisite Service Period Recognition

'

'

312,900

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Based Compensation to be Amortized Next Fiscal Year

135,900

'

135,900

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Based Compensation to be Amortized Vesting Period

'

'

'2014

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Based Compensation to be Amortized Depending on Certain Performance Conditions

177,000

'

177,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)

'

'

950,000

'

'

'

'

'

'

'

950,000

'

'

'

'

'

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)

'

'

$1.77

'

'

'

'

'

'

'

$1.77

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value

'

'

'

'

'

'

'

'

'

1,671,250

1,671,250

416,150

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)

'

'

'

'

'

'

'

'

'

$0.91

$0.91

'

'

'

'

'

Compensation Expenses Unamortized Period

'

'

31-Dec-15

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost

221,548

'

221,548

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Arrangement by Share Based Payment Award Accelerated Compensation Cost Per Share Basic (in Dollars per share)

$0.01

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Arrangement by Share Based Payment Award Accelerated Compensation Cost Per Share Diluted (in Dollars per share)

$0.01

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

Unamortized Debt Issuance Expense

221,548

'

221,548

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options

'

'

'

'

'

'

'

'

'

$867,683

$867,683

'

'

'

'

'

ACCOUNTING_FOR_STOCK_BASED_COM3

ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain officers and directors (Restricted Stock [Member], USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain officers and directors [Line Items]	'	'
Number of Shares Granted	220,000	258,696
Chief Executive Officer [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain officers and directors [Line Items]	'	'
Number of Shares Granted	'	50,000
Price per Granted Share (in Dollars per share)	'	1.15
Vesting Date	'	13-Jun-12
Chief Executive Officer Two [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain officers and directors [Line Items]	'	'
Number of Shares Granted	'	26,957
Price per Granted Share (in Dollars per share)	'	1.15
Vesting Date	'	20-Mar-13
V P Of Sales And Marketing [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain officers and directors [Line Items]	'	'
Number of Shares Granted	'	21,739
Price per Granted Share (in Dollars per share)	'	1.15
Vesting Date	'	20-Mar-13
Board Of Directors [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain officers and directors [Line Items]	'	'
Number of Shares Granted	'	80,000
Price per Granted Share (in Dollars per share)	'	1.15
Vesting Date	'	13-Jun-12
Board Of Directors Two [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain officers and directors [Line Items]	'	'
Number of Shares Granted	'	80,000
Price per Granted Share (in Dollars per share)	'	1.15
Vesting Date	'	13-Jun-13

ACCOUNTING_FOR_STOCK_BASED_COM4

ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Restricted Stock [Member] | Performance Based Restricted Common Stock Awards [Member] | Chief Executive Officer [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	42,000	'
Price per Granted Share (in Dollars per share)	1.77	'
Vesting Date	'Performance based	'
Restricted Stock [Member] | Performance Based Restricted Common Stock Awards [Member] | Chief Financial Officer [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	11,000	'
Price per Granted Share (in Dollars per share)	1.77	'
Vesting Date	'Performance based	'
Restricted Stock [Member] | Performance Based Restricted Common Stock Awards [Member] | V P Of Sales And Marketing [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	26,000	'
Price per Granted Share (in Dollars per share)	1.77	'
Vesting Date	'Performance based	'
Restricted Stock [Member] | Performance Based Restricted Common Stock Awards [Member] | Various Other Employees [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	21,000	'
Price per Granted Share (in Dollars per share)	1.77	'
Vesting Date	'Performance based	'
Restricted Stock [Member] | Performance Based Restricted Common Stock Awards [Member] | Board Of Directors [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	120,000	'
Price per Granted Share (in Dollars per share)	1.51	'
Vesting Date	'Next Annual Meeting	'
Restricted Stock [Member] | Performance Based Restricted Common Stock Awards [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	220,000	'
Restricted Stock [Member] | Chief Executive Officer [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	'	50,000
Price per Granted Share (in Dollars per share)	'	1.15
Restricted Stock [Member] | V P Of Sales And Marketing [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	'	21,739
Price per Granted Share (in Dollars per share)	'	1.15
Restricted Stock [Member] | Board Of Directors [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	'	80,000
Price per Granted Share (in Dollars per share)	'	1.15
Restricted Stock [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	220,000	258,696
Various Other Employees [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of restricted common stock awards granted to certain directors, officers and employees [Line Items]	'	'
Number of Shares Granted	100,000	'

ACCOUNTING_FOR_STOCK_BASED_COM5

ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of non-vested restricted stock activity (Restricted Stock [Member], USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Restricted Stock [Member]	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of non-vested restricted stock activity [Line Items]	'	'
Non-vested at January 1, 2013	128,696	'
Non-vested at January 1, 2013 (in Dollars per share)	$1.15	'
Granted	220,000	258,696
Granted (in Dollars per share)	$1.63	'
Vested	-128,696	'
Vested (in Dollars per share)	$1.15	'
Non-vested at September 30, 2013	220,000	'
Non-vested at September 30, 2013 (in Dollars per share)	$1.63	'

ACCOUNTING_FOR_STOCK_BASED_COM6

ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of performance-based stock option activity, and related information (USD $)	9 Months Ended
	Sep. 30, 2013
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of performance-based stock option activity, and related information [Line Items]	'
Granted	950,000
Granted (in Dollars per share)	$1.77
Performance Based Stock Options [Member]	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of performance-based stock option activity, and related information [Line Items]	'
Outstanding, January 1, 2013	1,300,000
Outstanding, January 1, 2013 (in Dollars per share)	$0.93
Granted	950,000
Granted (in Dollars per share)	$1.77
Outstanding, September 30, 2013	2,250,000
Outstanding, September 30, 2013 (in Dollars per share)	$1.28

ACCOUNTING_FOR_STOCK_BASED_COM7

ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of service-based stock option activity, and related information (Service Based Stock Options [Member], USD $)	9 Months Ended
	Sep. 30, 2013
Service Based Stock Options [Member]	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of service-based stock option activity, and related information [Line Items]	'
Outstanding, January 1, 2013	862,000
Outstanding, January 1, 2013 (in Dollars per share)	$2.61
Canceled/Expired	-20,000
Canceled/Expired (in Dollars per share)	$1.95
Outstanding, September 30, 2013	842,000
Outstanding, September 30, 2013 (in Dollars per share)	$2.63
Options exercisable, September 30, 2013	842,000
Options exercisable, September 30, 2013 (in Dollars per share)	$2.63

ACCOUNTING_FOR_STOCK_BASED_COM8

ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of share-based compensation expense, components by equity type (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of share-based compensation expense, components by equity type [Line Items]	'	'	'	'
Share Based Compensation	$316,081	$90,899	$479,214	$218,464
Performance Shares [Member]	'	'	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of share-based compensation expense, components by equity type [Line Items]	'	'	'	'
Share Based Compensation	270,781	49,232	369,246	147,697
Restricted Stock [Member]	'	'	'	'
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) - Schedule of share-based compensation expense, components by equity type [Line Items]	'	'	'	'
Share Based Compensation	$45,300	$41,667	$109,968	$70,767

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
SEGMENT INFORMATION (Details) [Line Items]	'	'	'	'
Number of Reportable Segments	'	'	2	'
United States [Member]	'	'	'	'
SEGMENT INFORMATION (Details) [Line Items]	'	'	'	'
Revenue, Net	$6,169,718	$5,227,114	$17,820,068	$14,849,766
China [Member]	'	'	'	'
SEGMENT INFORMATION (Details) [Line Items]	'	'	'	'
Revenue, Net	$869,298	$211,429	$1,319,804	$1,057,909

SEGMENT_INFORMATION_Details_Sc

SEGMENT INFORMATION (Details) - Schedule of financial information by reportable segment excluding assets (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Net sales by segment:	'	'	'	'
Net sales by segment	$8,790,954	$7,385,241	$24,292,829	$21,379,106
Segment income:	'	'	'	'
Segment income	1,908,456	1,574,785	4,755,650	4,282,108
Other unallocated amounts:	'	'	'	'
Corporate expenses	-1,336,682	-801,916	-3,222,220	-2,348,814
Interest and other income - net	160,536	-47,157	375,793	-16,562
Consolidated income before income tax (benefit)	732,310	725,712	1,909,223	1,916,732
Depreciation and amortization by segment:	'	'	'	'
Depreciation and amortization by segment	79,562	88,492	247,762	257,993
Capital expenditures by segment:	'	'	'	'
Capital expenditures by segment	'	'	352,747	293,781
Test and Measurement [Member]	'	'	'	'
Net sales by segment:	'	'	'	'
Net sales by segment	2,519,184	4,297,887	8,273,080	11,745,402
Segment income:	'	'	'	'
Segment income	125,540	976,914	660,712	2,124,823
Depreciation and amortization by segment:	'	'	'	'
Depreciation and amortization by segment	48,366	70,114	161,142	206,979
Capital expenditures by segment:	'	'	'	'
Capital expenditures by segment	85,048	58,296	218,427	167,199
Network Solutions [Member]	'	'	'	'
Net sales by segment:	'	'	'	'
Net sales by segment	6,271,770	3,087,354	16,019,749	9,633,704
Segment income:	'	'	'	'
Segment income	1,782,916	597,871	4,094,938	2,157,285
Depreciation and amortization by segment:	'	'	'	'
Depreciation and amortization by segment	31,196	18,378	86,620	51,014
Capital expenditures by segment:	'	'	'	'
Capital expenditures by segment	82,105	17,077	134,320	126,582
Continuing Operations Only [Member]	'	'	'	'
Capital expenditures by segment:	'	'	'	'
Capital expenditures by segment	$167,153	$75,373	$352,747	$293,781

SEGMENT_INFORMATION_Details_Sc1

SEGMENT INFORMATION (Details) - Schedule of financial information by reportable segment assets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Total assets by segment:	'	'
Total assets by segment	$18,873,965	$20,969,241
Corporate assets, principally cash and cash equivalents and deferred and current taxes	22,302,921	20,260,383
Total consolidated assets	41,176,886	41,229,624
Test and Measurement [Member]	'	'
Total assets by segment:	'	'
Total assets by segment	8,621,496	12,104,700
Network Solutions [Member]	'	'
Total assets by segment:	'	'
Total assets by segment	$10,252,469	$8,864,541

SEGMENT_INFORMATION_Details_Sc2

SEGMENT INFORMATION (Details) - Schedule of net consolidated sales by region (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
SEGMENT INFORMATION (Details) - Schedule of net consolidated sales by region [Line Items]	'	'	'	'
Revenues	$8,790,954	$7,385,241	$24,292,829	$21,379,106
Americas [Member]	'	'	'	'
SEGMENT INFORMATION (Details) - Schedule of net consolidated sales by region [Line Items]	'	'	'	'
Revenues	6,645,495	5,589,376	19,149,306	16,011,211
Europe, Middle East, Africa [Member]	'	'	'	'
SEGMENT INFORMATION (Details) - Schedule of net consolidated sales by region [Line Items]	'	'	'	'
Revenues	986,834	1,360,022	2,990,043	3,495,931
Asia Pacific [Member]	'	'	'	'
SEGMENT INFORMATION (Details) - Schedule of net consolidated sales by region [Line Items]	'	'	'	'
Revenues	$1,158,625	$435,843	$2,153,480	$1,871,964

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Warranties Period of Product	'1 year
Lease Expiration Date	30-Sep-14
Minimum Monthly Rent Payment	$29,000
Line of Credit Availability Equal to Percent of Money Market Account	100.00%
Line of Credit Availability Equal to Percent of Short-term Investment	99.00%
Annual fee under line of credit agreement	0
Line of Credit Facility, Amount Outstanding	0
Line of Credit Facility, Maximum Borrowing Capacity	$4,500,000

SALE_OF_BUILDING_Details

SALE OF BUILDING (Details) (USD $)	9 Months Ended
	Sep. 30, 2013
Property, Plant and Equipment [Abstract]	'
Escrow Deposit	$350,000
Required Monthly Payments For Mortgage Payable	23,750
Debt Instrument, Interest Rate, Stated Percentage	7.45%
Gain (Loss) on Disposition of Property Plant Equipment	$188,403